Inventor
DUBENSKY JR THOMAS W
US52 patents
⚠️ This page may combine multiple inventors who share the name “DUBENSKY JR THOMAS W”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
CHIRON CORP
14 patentsUS6342372B1Jan 29, 2002
Eukaryotic layered vector initiation systems for production of recombinant proteins
CHIRON CORP90 citations99
US6376236B1Apr 23, 2002
Recombinant alphavirus particles
CHIRON CORP121 citations98
US5843723ADec 1, 1998
Alphavirus vector constructs
CHIRON CORP327 citations98
US5789245AAug 4, 1998
Alphavirus structural protein expression cassettes
CHIRON CORP345 citations98
US6329201B1Dec 11, 2001
Compositions and methods for packaging of alphavirus vectors
CHIRON CORP86 citations97
US6015694AJan 18, 2000
Method for stimulating an immune response utilizing recombinant alphavirus particles
CHIRON CORP228 citations97
US6465634B1Oct 15, 2002
Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis
CHIRON CORP45 citations96
US6451592B1Sep 17, 2002
Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis
CHIRON CORP50 citations96
US6426196B1Jul 30, 2002
Alphavirus structural protein expression cassettes
CHIRON CORP57 citations96
US6391632B1May 21, 2002
Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis
CHIRON CORP63 citations96
US6242259B1Jun 5, 2001
Compositions and methods for packing of alphavirus vectors
CHIRON CORP85 citations95
US6767699B2Jul 27, 2004
Method for the quantitation of alphavirus replicon particles
CHIRON CORP50 citations92
US6458560B1Oct 1, 2002
Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis
CHIRON CORP37 citations90
US6730297B1May 4, 2004
Use of recombinant gene delivery vectors for treating or preventing lysosomal storage disorders
CHIRON CORP41 citations89
ADURO BIOTECH INC
11 patentsUS9549944B2Jan 24, 2017
Compositions and methods for inhibiting “stimulator of interferon gene”—dependent signalling
ADURO BIOTECH INC53 citations97
US9695212B2Jul 4, 2017
Compositions comprising cyclic purine dinucleotides having defined stereochemistries and methods for their preparation and use
ADURO BIOTECH INC48 citations96
US9724408B2Aug 8, 2017
Compositions and methods for activating stimulator of interferon gene-dependent signalling
ADURO BIOTECH INC54 citations94
US9198960B2Dec 1, 2015
Methods and compositions using listeria for enhancing immunogenicity by prime boost
ADURO BIOTECH INC23 citations91
US10189873B2Jan 29, 2019
Compositions and methods for inhibiting “stimulator of interferon gene”-dependent signalling
ADURO BIOTECH INC10 citations84
US10414789B2Sep 17, 2019
Compositions comprising cyclic purine dinucleotides having defined stereochemistries and methods for their preparation and use
ADURO BIOTECH INC8 citations82
US10653774B2May 19, 2020
Compositions and methods for activating “stimulator of interferon gene”-dependent signalling
ADURO BIOTECH INC5 citations81
US10449211B2Oct 22, 2019
Compositions and methods for activating “stimulator of interferon gene”—dependent signalling
ADURO BIOTECH INC7 citations80
US9878024B2Jan 30, 2018
Methods and compositions using Listeria for enhancing immunogenicity by prime boost
ADURO BIOTECH INC3 citations71
US9663557B2May 30, 2017
Signal peptide fusion partners facilitating listerial expression of antigenic sequences and methods of preparation and use thereof
ADURO BIOTECH INC2 citations68
US10906930B2Feb 2, 2021
Compositions and methods for activating “stimulator of interferon gene”-dependent signalling
ADURO BIOTECH INC3 citations67
NOVARTIS VACCINES & DIAGNOSTIC
5 patentsUS7977091B2Jul 12, 2011
Eukaryotic layered vector initiation systems
NOVARTIS VACCINES & DIAGNOSTIC38 citations96
US7811812B2Oct 12, 2010
Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis
NOVARTIS VACCINES & DIAGNOSTIC43 citations94
US7744900B2Jun 29, 2010
Enhancement of the immune response for vaccine and gene therapy applications
NOVARTIS VACCINES & DIAGNOSTIC20 citations92
US7572628B2Aug 11, 2009
Eukaryotic layered vector initiation systems
NOVARTIS VACCINES & DIAGNOSTIC9 citations92
US7771979B2Aug 10, 2010
Compositions and methods for generating an immune response utilizing alphavirus-based vector systems
NOVARTIS VACCINES & DIAGNOSTIC39 citations91
ADURO BIOTECH
5 patentsUS7935804B2May 3, 2011
Engineered Listeria and methods of use thereof
ADURO BIOTECH32 citations92
US7833775B2Nov 16, 2010
Modified free-living microbes, vaccine compositions and methods of use thereof
ADURO BIOTECH21 citations92
US7842289B2Nov 30, 2010
Recombinant nucleic acid molecules, expression cassettes, and bacteria, and methods of use thereof
ADURO BIOTECH23 citations91
US7695725B2Apr 13, 2010
Modified free-living microbes, vaccine compositions and methods of use thereof
ADURO BIOTECH14 citations91
US7927606B2Apr 19, 2011
Modified free-living microbes, vaccine compositions and methods of use thereof
ADURO BIOTECH5 citations72
DUBENSKY JR THOMAS W
4 patentsUS8287883B2Oct 16, 2012
Listeria attenuated for entry into non-phagocytic cells, vaccines comprising the Listeria, and methods of use thereof
DUBENSKY JR THOMAS W17 citations92
US9044420B2Jun 2, 2015
Immunogenic compositions and methods of using the compositions for inducing humoral and cellular immune responses
DUBENSKY JR THOMAS W43 citations91
US8926993B2Jan 6, 2015
Methods and compositions using Listeria for enhancing immunogenicity by prime boost
DUBENSKY JR THOMAS W26 citations89
US8580939B2Nov 12, 2013
Engineered Listeria and methods of use thereof
DUBENSKY JR THOMAS W3 citations61
IMMUNE DESIGN CORP
3 patents(unassigned)
2 patentsVIAGENE INC
1 patentUNIV JOHNS HOPKINS
1 patentANZA THERAPEUTICS INC
1 patentALLEN JAMES M
1 patentPOLO JOHN M
1 patentUNIV IOWA RES FOUND
1 patentShowing the top 50 of 52 patents by PatentIndex Score.